JP2025023300A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025023300A5 JP2025023300A5 JP2024212569A JP2024212569A JP2025023300A5 JP 2025023300 A5 JP2025023300 A5 JP 2025023300A5 JP 2024212569 A JP2024212569 A JP 2024212569A JP 2024212569 A JP2024212569 A JP 2024212569A JP 2025023300 A5 JP2025023300 A5 JP 2025023300A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- hydroxy
- pharma
- halogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110277849 | 2021-03-15 | ||
| CN202110277849.3 | 2021-03-15 | ||
| PCT/CN2022/080680 WO2022194096A1 (zh) | 2021-03-15 | 2022-03-14 | 雌激素受体调节剂 |
| JP2023557230A JP7605536B2 (ja) | 2021-03-15 | 2022-03-14 | エストロゲン受容体モジュレーター |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557230A Division JP7605536B2 (ja) | 2021-03-15 | 2022-03-14 | エストロゲン受容体モジュレーター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025023300A JP2025023300A (ja) | 2025-02-14 |
| JP2025023300A5 true JP2025023300A5 (https=) | 2025-03-26 |
Family
ID=83246765
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557230A Active JP7605536B2 (ja) | 2021-03-15 | 2022-03-14 | エストロゲン受容体モジュレーター |
| JP2024212569A Pending JP2025023300A (ja) | 2021-03-15 | 2024-12-05 | エストロゲン受容体モジュレーター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557230A Active JP7605536B2 (ja) | 2021-03-15 | 2022-03-14 | エストロゲン受容体モジュレーター |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217988A1 (https=) |
| EP (1) | EP4310079A4 (https=) |
| JP (2) | JP7605536B2 (https=) |
| KR (1) | KR20230157439A (https=) |
| CN (2) | CN115073493B (https=) |
| AU (1) | AU2022240650B2 (https=) |
| WO (1) | WO2022194096A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7605536B2 (ja) * | 2021-03-15 | 2024-12-24 | 深▲せん▼福沃薬業有限公司 | エストロゲン受容体モジュレーター |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667316B1 (en) * | 1999-11-12 | 2003-12-23 | Celgene Corporation | Pharmaceutically active isoindoline derivatives |
| WO2012142029A2 (en) * | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
| CN104910137B (zh) * | 2014-03-10 | 2017-04-19 | 山东轩竹医药科技有限公司 | Cdk激酶抑制剂 |
| KR20180012853A (ko) * | 2015-06-16 | 2018-02-06 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 피페리딘 유도체 및 이의 제조 방법 및 약학적 용도 |
| US9969732B2 (en) | 2016-04-08 | 2018-05-15 | Genentech, Inc. | Tetrahydroisoquinoline estrogen receptor modulators and uses thereof |
| US10125135B2 (en) * | 2016-04-20 | 2018-11-13 | Astrazeneca Ab | Chemical compounds |
| WO2018138739A1 (en) * | 2017-01-27 | 2018-08-02 | Sun Pharma Advanced Research Company Limited | Novel antiestrogenic heterocyclic compounds |
| WO2019192533A1 (zh) * | 2018-04-04 | 2019-10-10 | 深圳福沃药业有限公司 | 用于治疗乳腺癌的雌激素受体降解剂 |
| TW202003495A (zh) * | 2018-05-23 | 2020-01-16 | 大陸商江蘇恒瑞醫藥股份有限公司 | 苯並哌啶或雜芳基並哌啶類衍生物、其製備方法及其在醫藥上的應用 |
| JP7605536B2 (ja) * | 2021-03-15 | 2024-12-24 | 深▲せん▼福沃薬業有限公司 | エストロゲン受容体モジュレーター |
-
2022
- 2022-03-14 JP JP2023557230A patent/JP7605536B2/ja active Active
- 2022-03-14 KR KR1020237035079A patent/KR20230157439A/ko active Pending
- 2022-03-14 CN CN202210249231.0A patent/CN115073493B/zh active Active
- 2022-03-14 AU AU2022240650A patent/AU2022240650B2/en active Active
- 2022-03-14 CN CN202510027136.XA patent/CN119930646A/zh active Pending
- 2022-03-14 US US18/282,147 patent/US20240217988A1/en active Pending
- 2022-03-14 WO PCT/CN2022/080680 patent/WO2022194096A1/zh not_active Ceased
- 2022-03-14 EP EP22770451.7A patent/EP4310079A4/en active Pending
-
2024
- 2024-12-05 JP JP2024212569A patent/JP2025023300A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024050527A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2021169467A5 (https=) | ||
| JP2025023300A5 (https=) | ||
| RU2214406C2 (ru) | Лиганды рецептора h3 гистамина | |
| JP2005511699A5 (https=) | ||
| JPWO2019241157A5 (https=) | ||
| JP2009534404A5 (https=) | ||
| JP2022081661A5 (https=) | ||
| JP2006501295A5 (https=) | ||
| RU2007128061A (ru) | Индазол-карбоксамидные соединения | |
| JP2008525466A5 (https=) | ||
| JP2002505286A5 (https=) | ||
| JPWO2020081999A5 (https=) | ||
| JP2002533335A5 (https=) | ||
| JPWO2019165358A5 (https=) | ||
| JP2025160175A5 (https=) | ||
| EP2669280B1 (en) | Bicyclic compound and use thereof for medical purposes | |
| JP2004534781A5 (https=) | ||
| JP2007509175A5 (https=) | ||
| JPWO2019222266A5 (https=) | ||
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| JP2004521913A5 (https=) | ||
| JPWO2023016529A5 (https=) | ||
| JPWO2019236884A5 (https=) |